Diabetes a obezita
Current issue
Most read in this issue
- The dual GIP and GLP1 receptor agonist tirzepatide: a new effective treatment for type 2 diabetes mellitus
- Practical experience with dapagliflozin: case reports
- The patient with type 2 diabetes is hemodynamically and metabolically stable, despite treatment, the progression of chronic kidney disease proceeds. What other options do we have? A case report
- Quo vadis, slovenská diabetológia?